Vertex Pharmaceuticals Inc (VRTX) — Cash Flow Quality Index
Vertex Pharmaceuticals Inc (VRTX) has a Cash Flow Quality Index of 1.02x as of June 2026. Operating cash flow of $1.13 Billion exceeds net income of $1.10 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Vertex Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vertex Pharmaceuticals Inc Cash Flow Quality Index (1993–2025)
Historical Cash Flow Quality Index for Vertex Pharmaceuticals Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see VRTX cash generation efficiency.
Annual Cash Flow Quality Index for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year earnings quality comparison for Vertex Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | $3.63 Billion | $3.95 Billion | ▼ -6.0% |
| 2023 | 0.98x | $3.54 Billion | $3.62 Billion | ▼ -21.4% |
| 2022 | 1.24x | $4.13 Billion | $3.32 Billion | ▲ +10.1% |
| 2021 | 1.13x | $2.64 Billion | $2.34 Billion | ▼ -5.9% |
| 2020 | 1.20x | $3.25 Billion | $2.71 Billion | ▼ -10.0% |
| 2019 | 1.33x | $1.57 Billion | $1.18 Billion | ▲ +119.1% |
| 2018 | 0.61x | $1.27 Billion | $2.09 Billion | ▼ -93.4% |
| 2017 | 9.22x | $844.94 Million | $91.64 Million | ▲ +164.2% |
| 2011 | 3.49x | $143.74 Million | $41.18 Million | ▼ -18.8% |
| 1993 | 4.30x | $8.60 Million | $2.00 Million | — |